A team from the Beaumont Research Institute believes low-dose radiation might be a promising treatment for Alzheimer’s disease. The researchers are now seeking patients with Alzheimer’s disease for the study.Read more
A paper published today in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, researchers at Beth Israel Deaconess Medical Center (BIDMC) shed new light on a genetic risk factor for Alzheimer’s disease that may indirectly influence patients’ risk of postoperative delirium.Read more
A gene called apolipoprotein E (APOE), long implicated in Alzheimer’s disease, has two variants that act differently among Caribbean Hispanics depending on the ancestral origin, according to a study published in Alzheimer’s and Dementia, the journal of the Alzheimer’s Association.Read more
The advisory council is made up of federal and non-federal members who serve overlapping four-year terms. As a new member, Ordóñez brings the perspectives of Hispanic and Latino Americans and providers of long-term services and support.Read more
A UCLA-led study finds that, with the use of MRI scans, it is possible to distinguish between memory loss caused by Alzheimer’s disease and traumatic brain injury.Read more
Older people who experienced more hospitalizations and also had more Alzheimer’s pathology in their brain experienced the fastest rates of cognitive decline, according to study results published in the October 15 online issue of the Annals of Neurology.Read more
Everybody knows sleep is good for your body. It may be good for your mind, too.
That’s what scientists at Wake Forest School of Medicine will attempt to determine thanks to a $5.3 million grant from the National Institute on Aging, part of the National Institutes of Health.
Irvine, Calif., Aug. 21, 2019 — Scientists from the University of California, Irvine School of Biological Sciences have discovered how to forestall Alzheimer’s disease in a laboratory setting, a finding that could one day help in devising targeted drugs that prevent it. The researchers found that by removing brain immune cells known as microglia from rodent models of Alzheimer’s disease, beta-amyloid plaques – the hallmark pathology of AD – never formed.Read more